|
Medical Device News
PRESS RELEASE ARCHIVES FROM SEND2PRESS® NEWSWIRE
NOTICE: THIS IS ARCHIVAL CONTENT AND LIKELY OUT OF DATE.
Article Editor: Christopher Laird Simmons
'Gate-Keeper' Patent Granted For Novel Germicidal Device To Help Prevent Hospital-Acquired (Nosocomial) Infections
BOSTON, MA - May 19, 2004 /Send2Press Newswire/ -- Catheter site infections are among the
most common and serious nosocomial infections. UVSolutions (www.uvs-ultraclean.com)
announces its patented catheter site disinfection system, also patented for wound care,
is a safe, effective, painless, low-cost disinfection solution.
Hospital-acquired (nosocomial) infection affects 1 in 20 patients and kills more people
than car accidents and homicides combined. The CDC estimated that in the U.S. in 1995,
nosocomial infections cost $4.5 billion and contributed to more than 88,000 deaths -- one
death every 6 minutes.
Catheters routinely provide hospitalized patients with medication, nutrition, hydration
etc. The largest single cause of catheter related infections is colonization of
microorganisms around the catheter entry site, under the dressing. The microorganisms
multiply and migrate down the outside of the catheter into the blood stream.
UVSolutions has developed a novel system to significantly reduce colonization of
microorganisms around the catheter site. The disinfection system includes a palm-sized,
battery operated ultraviolet C light placed over the catheter site to deliver a single
flash of UVC light through a custom dressing. UVSolutions plans to partner with market
leaders to commercialize the catheter site disinfection system and the wound care system.
"UVSolutions' proprietary flash-based germicidal ultra violet (UVC) sterilization
technology for medical and consumer applications has a greater than 99.9% efficacy in
killing bacteria, viruses, mold, and fungi. UVC does not contribute to the development of
resistant strains of microorganisms, as do other antimicrobials and antibiotics," reports
Geoff Jenkins, President of the Boston-based company.
UVSolutions' medical infection control products provide revolutionary low-cost, non-
chemical sterilization and disinfection solutions to help reduce escalating incidences
and costs associated with nosocomial infections.
UVSolutions' consumer products provide families with low cost, non-chemical,
antimicrobial personal care and water purification products in the wake of increasing
demand for infection control products. UVSolutions has licensed a number of personal care
products to a leading U.S. home appliance company; the products will be commercially
available later this year.
UVSolutions LLC is a privately held product development company in Wellesley,
Massachusetts. The Company licenses its proprietary products to market leaders. Other
products under development include a stethoscope disinfector and rapid germicidal water
purification products for home, travel and personal use. UVSolutions holds several
patents including the newly issued U.S. Patent 6,730,113.
DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the organization mentioned and/or quoted in the story. The organization providing the news to Send2Press is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements and public companies should be thoroughly researched before considering material investment. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
USE OF THE ABOVE NEWS ARTICLE
Article is Copr. © 2004 Neotrope/Send2Press. Reproduction of this news article in any form requires written authorization. You may freely link to this article.
|
